{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:14:06Z","timestamp":1793830446271,"version":"4.6.1"},"reference-count":23,"publisher":"Society of Nuclear Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.2967\/jnumed.122.264890","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T11:13:07Z","timestamp":1689851587000},"page":"1406-1411","source":"Crossref","is-referenced-by-count":40,"title":["Head-to-Head Comparison of\n                    <sup>68<\/sup>\n                    Ga-NODAGA-JR11 and\n                    <sup>68<\/sup>\n                    Ga-DOTATATE PET\/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: Interim Analysis of a Prospective Bicenter Study"],"prefix":"10.2967","volume":"64","author":[{"given":"Zefang","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"2023091409501493000_64.9.1406.1","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s00259-017-3728-y","article-title":"Guideline for PET\/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA","volume":"44","author":"Bozkurt","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023091409501493000_64.9.1406.2","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s00259-020-04918-4","article-title":"[18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients","volume":"47","author":"Pauwels","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023091409501493000_64.9.1406.3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0607761103"},{"key":"2023091409501493000_64.9.1406.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.088922"},{"key":"2023091409501493000_64.9.1406.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.102764"},{"key":"2023091409501493000_64.9.1406.6","doi-asserted-by":"crossref","first-page":"e0195802","DOI":"10.1371\/journal.pone.0195802","article-title":"The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model","volume":"13","author":"Rylova","year":"2018","journal-title":"PLoS One."},{"key":"2023091409501493000_64.9.1406.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.191684"},{"key":"2023091409501493000_64.9.1406.8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13550-016-0204-9","article-title":"177Lu-OPS201 targeting somatostatin receptors: in\u00a0vivo biodistribution and dosimetry in a pig model","volume":"6","author":"Beykan","year":"2016","journal-title":"EJNMMI Res."},{"key":"2023091409501493000_64.9.1406.9","first-page":"709","article-title":"Identification and characterization of novel somatostatin antagonists","volume":"50","author":"Bass","year":"1996","journal-title":"Mol Pharmacol."},{"key":"2023091409501493000_64.9.1406.10","unstructured":"Leung K . 68Ga-1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid-Cpa-cyclo(d-Cys-amino-Phe-hydroorotic acid-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)-D-Tyr-NH2 (JR11). In: MICAD: Molecular Imaging & Contrast Agent Database. National Center for Biotechnology Information; 2012."},{"key":"2023091409501493000_64.9.1406.11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/RLU.0000000000003732","article-title":"68Ga-DOTATATE and 68Ga-NODAGA-JR11 PET\/CT images in a patient with gastric neuroendocrine tumor","volume":"46","author":"Lin","year":"2021","journal-title":"Clin Nucl Med."},{"key":"2023091409501493000_64.9.1406.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.199760"},{"key":"2023091409501493000_64.9.1406.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.235093"},{"key":"2023091409501493000_64.9.1406.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.261936"},{"key":"2023091409501493000_64.9.1406.15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/jlcr.3755","article-title":"Design and development of the theranostic pair 177Lu-OPS201\/68Ga-OPS202 for targeting somatostatin receptor expressing tumors","volume":"62","author":"Mansi","year":"2019","journal-title":"J Labelled Comp Radiopharm."},{"key":"2023091409501493000_64.9.1406.16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1026"},{"key":"2023091409501493000_64.9.1406.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-015-0409-9"},{"key":"2023091409501493000_64.9.1406.18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000479293","article-title":"Morphological and functional imaging for detecting and assessing the resectability of neuroendocrine liver metastases","volume":"106","author":"Ronot","year":"2018","journal-title":"Neuroendocrinology."},{"key":"2023091409501493000_64.9.1406.19","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1007\/s00261-021-02990-4","article-title":"68Ga-DOTATATE PET\/CT compared to standard imaging in metastatic neuroendocrine tumors: a more sensitive test to detect liver metastasis?","volume":"46","author":"Jackson","year":"2021","journal-title":"Abdom Radiol (NY)."},{"key":"2023091409501493000_64.9.1406.20","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00259-021-05512-y","article-title":"A prospective randomized, double-blind study to evaluate the diagnostic efficacy of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors: compared with 68Ga-DOTATATE","volume":"49","author":"Zhu","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023091409501493000_64.9.1406.21","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/RLU.0000000000000863","article-title":"Intrapancreatic accessory spleen mimicking neuroendocrine tumor on 68Ga-DOTATATE PET\/CT","volume":"40","author":"Bhure","year":"2015","journal-title":"Clin Nucl Med."},{"key":"2023091409501493000_64.9.1406.22","doi-asserted-by":"crossref","first-page":"39e","DOI":"10.1177\/030089161109700625","article-title":"Accessory spleen mimicking a pancreatic neuroendocrine tumor","volume":"97","author":"Suriano","year":"2011","journal-title":"Tumori."},{"key":"2023091409501493000_64.9.1406.23","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1097\/RLU.0000000000002906","article-title":"Successful intra-arterial peptide receptor radionuclide therapy of DOTATOC-negative high-grade liver metastases of a pancreatic neuroendocrine neoplasm using 177Lu-DOTA-LM3: a somatostatin receptor antagonist","volume":"45","author":"Zhang","year":"2020","journal-title":"Clin Nucl Med."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.122.264890","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T12:54:04Z","timestamp":1694696044000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.122.264890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,1]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.2967\/jnumed.122.264890"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.122.264890","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]}}}